A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab vs dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent or persistent cervical carcinoma: Japan Clinical Oncology Group Study (JCOG1311)-Reference-Cited by-同舟云学术

A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab vs dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent or persistent cervical carcinoma: Japan Clinical Oncology Group Study (JCOG1311)

Published:2018-10-08 Issue:12 Volume:48 Page:1096-1100
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Ishikawa Mitsuya¹,Nakamura Kenichi²,Shibata Taro²,Tanaka Kiyo²,Kitagawa Ryo³,Kobayashi Hiroaki⁴,Yaegashi Nobuo⁵,

Affiliation:

1. Department of Gynecology, National Cancer Center Hospital, Tokyo, JAPAN

2. JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, JAPAN

3. Division of Obstetrics and Gynecology, Tohoku Medical and Pharmaceutical University, Miyagi, JAPAN

4. Department of Obstetrics & Gynecology, Faculty of Medicine, Kagoshima University, Kagoshima, JAPAN

5. Department of Obstetrics and Gynecology, Tohoku University School of Medicine, Miyagi, JAPAN

Funder

National Cancer Center Research and Development Fund

Medical Research and Development

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/48/12/1096/26751316/hyy137.pdf

Reference12 articles.

1. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study;Moore;J Clin Oncol,2004

2. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study;Long;J Clin Oncol,2005

3. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study;Monk;J Clin Oncol,2009

4. Improved survival with bevacizumab in advanced cervical cancer;Tewari;N Engl J Med,2014

5. A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer;Kitagawa;Gynecol Oncol,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Final analysis of a randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311);International Journal of Gynecologic Cancer;2023-03-30

2. Dynamic Nomogram Based on the Metastatic Number and Sites and Therapy Strategies Predicting the Prognosis of Patients with Metastatic Cervical Cancer;International Journal of Women's Health;2022-12

3. Hypoalbuminemia for the prediction of survival in patients with stage IVB cervical cancer;PLOS ONE;2022-09-02

4. A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311): Primary analysis;Gynecologic Oncology;2021-08

5. Risk factors for dysgeusia during chemotherapy for solid tumors: a retrospective cross-sectional study;Supportive Care in Cancer;2021-07-20